Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NCR Voyix (VYX) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for NCR Voyix (VYX) over the last 13 years, with Sep 2025 value amounting to $3.0 million.

  • NCR Voyix's Gains from Investment Securities changed negligibly% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year decrease of 60.00%. This contributed to the annual value of $14.0 million for FY2024, which is 58.82% down from last year.
  • NCR Voyix's Gains from Investment Securities amounted to $3.0 million in Q3 2025, which was up 200.00% from $1.0 million recorded in Q2 2025.
  • NCR Voyix's Gains from Investment Securities' 5-year high stood at $36.0 million during Q1 2022, with a 5-year trough of $1.0 million in Q2 2024.
  • Over the past 3 years, NCR Voyix's median Gains from Investment Securities value was $3.0 million (recorded in 2025), while the average stood at $6.4 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first spiked by 2,100.00% in 2021, then slumped by 88.89% in 2024.
  • NCR Voyix's Gains from Investment Securities (Quarterly) stood at $22.0 million in 2021, then declined by 4.55% to $21.0 million in 2022, then dropped by 14.29% to $18.0 million in 2023, then crashed by 88.89% to $2.0 million in 2024, then remained steady at $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $1.0 million for Q2 2025, and $6.0 million during Q1 2025.